Axbio
PrivateLast Round
Series B
May 27, 2022
Est. Valuation
$239M
Total Funding Raised
$118.15M
Company Overview
Axbio is a semiconductor-biotechnology company that develops next-generation electrochemical detection platforms, including nanopore sequencing and Bio-CMOS chip technology for molecular diagnostics and life science research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Semiconductors, Sensors, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axbio Comparables
Compare Axbio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Roswell Biotechnologies | 86% | |
| Ultima Genomics | 85% | |
| Element Biosciences | 84% | |
Axbio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 27, 2022 | ||||
| Series A Extension | Oct 15, 2021 | ||||
| Series A | Aug 29, 2018 | ||||
| Seed | Oct 1, 2017 |
Axbio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SDIC Fund Management Co., Ltd. | Series B |
| Kaitai Capital | Series A Extension |
| MSA Capital | Series A Extension |
| CBC Group | Series B |
| 5Y Capital | Series B, Series A Extension |
| Yunfeng Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors increased 51% MoM.
- May 27, 2022
$70M round led by AstraZeneca-CICC Healthcare and Yunfeng Capital.
Axbio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Axbio's valuation, stock price, and market status.